All In MedTech

Company

Teoxane

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

From SEC filings.

We found no SEC financing filings under the name Teoxane, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

No 5%+ shareholder filings or SBIR grants found under the name Teoxane.

Latest FDA decisions

Search the Clearance Tracker

3 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar
  • RHA®4 for Midface Volume DeficiencyPivotal-lookingCompleted

    NCT05133739 · 201 participants · Start Oct 29, 2021 · Primary completion Jan 17, 2023

    Device: injection of RHA®4 in Midface; injection of Comparator Product in Midface · For: Cheek Augmentation; Correction of Age-related Midface Contour Deficiencies

    Sites: Chestnut Hill, Massachusetts

  • NCT04577898 · 248 participants · Start Dec 2, 2020 · Primary completion May 16, 2023

    Device: RHA® Redensity Eye · For: Infra-orbital Hollows; Tear-trough Deformity; Wrinkle

    Sites: Encino, California; Santa Monica, California; Coral Gables, Florida · 4 sites in all

  • NCT07145905 · 130 participants · Start Nov 30, 2023 · Primary completion Sep 30, 2025

    Device: TCRM · For: Skin Aging; Cheek Wrinkles

    Sites: Madrid, Spain

14 more trials with a free account

Reports received

88

Received Nov 1, 2025 to Nov 20, 2026

Malfunction reports

0

0.0% of reports

Injury reports

88

100% of reports

Death reports

0

0.0% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 2301100
Jan 240700
Feb 240600
Mar 2401200
Apr 2401100
May 2401200
Jun 240400
Jul 240500
Aug 2401700
Sep 240500
Oct 240800
Nov 240700
Dec 240800
Jan 250400
Feb 250400
Mar 2501200
Apr 2501100
May 2501500
Jun 2501200
Jul 250800
Aug 250200
Sep 250800
Oct 2501800
Nov 250400
Dec 250700
Jan 260300
Feb 2601400
Mar 260600
Apr 260400
May 2601100
Jun 260300
Jul 2601200
Aug 260600
Sep 2601000
Oct 260800
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recalls under this name in FDA's data.

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.